Hear from Prof. Cho Byoung Chul, Chief of the Lung Cancer Center in Yonsei Cancer Center in Seoul, South Korea as he shares his experience of using the Guardant360® test in his clinic. Prof. Cho describes how Guardant Health’s liquid biopsy test was useful in guiding treatment decisions for his patient with a rare genomic alteration as he enrolled the patient in a clinical trial at the center. Visit us at https://www.guardanthealthamea.com/resources/ to find out more about the Guardant360® test and how it can help guide treatment decisions for patients with advanced stage cancer.